A Kappeler
Adding cetuximab to capecitabine plus oxaliplatin (XELOX) in first-line treatment of metastatic colorectal cancer: a randomized phase II trial of the Swiss Group for Clinical Cancer Research SAKK
Borner M, Mingrone W, Lanz D, Dietrich D, Kappeler A, Roth A, Ruhstaller T, Caspar C, Pestalozzi B, Helbling D, Trojan A, Hess V, Rauch D, Saletti P, von Moos R, Koeberle D, Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland. Adding cetuximab to capecitabine plus oxaliplatin (XELOX) in first-line treatment of metastatic colorectal cancer: a randomized phase II trial of the Swiss Group for Clinical Cancer Research SAKK. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008; 19:1288-92.
01.07.2008Adding cetuximab to capecitabine plus oxaliplatin (XELOX) in first-line treatment of metastatic colorectal cancer: a randomized phase II trial of the Swiss Group for Clinical Cancer Research SAKK
01.07.2008Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008; 19:1288-92
Borner M, Mingrone W, Lanz D, Dietrich D, Kappeler A, Roth A, Ruhstaller Thomas, Caspar C, Pestalozzi B, Helbling D, Trojan A, Hess V, Rauch D, Saletti P, von Moos R, Koeberle D, Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland
T-cell-rich B-cell non-Hodgkin's lymphoma mimicking Hodgkin's disease
Bättig B, Mueller-Garamvoelgyi E, Cogliatti S, Schmid U, Kappeler A, Cerny T, Laissue J, Fey M. T-cell-rich B-cell non-Hodgkin's lymphoma mimicking Hodgkin's disease. Leukemia & lymphoma 1999; 33:393-8.
01.04.1999T-cell-rich B-cell non-Hodgkin's lymphoma mimicking Hodgkin's disease
01.04.1999Leukemia & lymphoma 1999; 33:393-8
Bättig B, Mueller-Garamvoelgyi E, Cogliatti S B, Schmid U, Kappeler A, Cerny Thomas, Laissue J A, Fey M F